Last reviewed · How we verify

NCT04982198

Robotic-assisted Versus Conventional Total Knee Arthroplasty

Completed NA Last updated 26 June 2023
What this trial tests

NA trial testing ROSA assisted TKA in Total Knee Arthoplasty in 99 participants. Completed in 31 May 2023.

Timeline
7 July 2021
Primary endpoint
30 December 2022
31 May 2023

Quick facts

Lead sponsorZimmer Biomet
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment99
Start date7 July 2021
Primary completion30 December 2022
Estimated completion31 May 2023
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Zimmer Biomet — full company profile →

Who can join

Adults 18 to 85, any sex, with Total Knee Arthoplasty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a multicenter, prospective and randomized controlled pre-market clinical Trial. Study subjects will be randomized into one of two operative groups: 1) TKA assisted with ROSA® Knee System; 2) TKA with conventional surgical instrumentation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Zimmer Biomet trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04982198.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing